Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:50 AM UTC
| NCT Number | NCT07196501 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | PHASE3 |
| Target Enrollment | 550 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Neurocrine Biosciences |
| Last Updated on CT.gov | July 24, 2026 (Jul 24, 2026) |
As of October 16, 2026: Clinical trial NCT07196501 is currently recruiting participants. This phase3 study for major depressive disorder is actively seeking new participants at 24 locations across the United States. The study is sponsored by Neurocrine Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07196501 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07196501 was last updated Jul 24, 2026 (July 24, 2026). HelloStudys verifies this status automatically.